Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,306 | 554 | 75.6% |
| Consulting Fee | $4,245 | 4 | 24.1% |
| Education | $59.94 | 3 | 0.3% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $4,003 | 42 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,722 | 57 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,686 | 25 | $0 (2020) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,520 | 76 | $0 (2024) |
| MAYNE PHARMA INC. | $1,184 | 68 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $849.13 | 7 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $684.93 | 16 | $0 (2023) |
| ABBVIE INC. | $652.89 | 27 | $0 (2024) |
| GENZYME CORPORATION | $621.95 | 30 | $0 (2024) |
| Medimetriks Pharmaceuticals, Inc. | $541.52 | 44 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,326 | 68 | SUN PHARMACEUTICAL INDUSTRIES INC. ($336.88) |
| 2023 | $1,040 | 55 | Dermavant Sciences, Inc. ($287.98) |
| 2022 | $820.30 | 26 | Novartis Pharmaceuticals Corporation ($253.18) |
| 2021 | $1,590 | 64 | MERZ NORTH AMERICA, INC. ($418.25) |
| 2020 | $1,200 | 68 | Sun Pharmaceutical Industries Inc. ($308.25) |
| 2019 | $2,201 | 88 | Mayne Pharma Inc. ($419.55) |
| 2018 | $5,958 | 105 | PFIZER INC. ($2,621) |
| 2017 | $3,475 | 89 | PFIZER INC. ($1,042) |
All Payment Transactions
563 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.12 | General |
| Category: Immunology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.39 | General |
| Category: Immunology | ||||||
| 11/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological), BLU-U | Food and Beverage | In-kind items and services | $92.13 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Immunology | ||||||
| 10/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $137.73 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: DERMATOLOGY | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Immunology | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: DERMATOLOGY | ||||||
| 08/27/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $30.55 | General |
| Category: Immunology | ||||||
| 08/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.01 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: DERMATOLOGY | ||||||
| 08/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Immunology | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.01 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Dermatology | ||||||
| 07/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.01 | General |
| Category: Immunology | ||||||
| 07/30/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: DERMATOLOGY | ||||||
| 07/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Immunology | ||||||
| 07/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $8.50 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,487 | 9,360 | $978,031 | $454,030 |
| 2022 | 26 | 3,731 | 9,563 | $942,243 | $460,654 |
| 2021 | 27 | 4,011 | 9,542 | $885,731 | $461,289 |
| 2020 | 25 | 4,032 | 9,885 | $835,916 | $411,615 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 751 | 3,221 | $241,575 | $116,776 | 48.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 852 | 1,631 | $293,580 | $109,966 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 659 | 1,372 | $164,640 | $87,716 | 53.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 281 | 388 | $73,720 | $35,906 | 48.7% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 188 | 462 | $36,960 | $18,755 | 50.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 82 | 113 | $21,470 | $11,838 | 55.1% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 54 | 81 | $24,300 | $11,192 | 46.1% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 12 | 34 | $15,300 | $10,420 | 68.1% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 55 | 77 | $19,250 | $7,815 | 40.6% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 42 | 53 | $10,600 | $7,040 | 66.4% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 33 | 36 | $9,000 | $4,474 | 49.7% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 12 | 23 | $7,475 | $3,796 | 50.8% |
| 17283 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 20 | 21 | $7,350 | $3,556 | 48.4% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 31 | 34 | $6,800 | $3,278 | 48.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 104 | 532 | $6,650 | $3,123 | 47.0% |
| 40490 | Biopsy of lip | Office | 2023 | 25 | 34 | $4,250 | $2,689 | 63.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 43 | 43 | $6,020 | $2,217 | 36.8% |
| 17273 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 12 | 14 | $3,640 | $2,137 | 58.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 24 | 28 | $4,760 | $2,108 | 44.3% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 18 | $2,790 | $2,069 | 74.2% |
| 67810 | Biopsy of eyelid | Office | 2023 | 16 | 17 | $3,706 | $2,040 | 55.0% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 18 | 19 | $2,565 | $1,913 | 74.6% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 20 | 20 | $3,700 | $1,224 | 33.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 30 | 35 | $2,660 | $1,099 | 41.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 105 | 1,054 | $5,270 | $881.06 | 16.7% |
About Dr. Robert Kaplan, MD
Dr. Robert Kaplan, MD is a Dermatology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750359543.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Kaplan, MD has received a total of $17,611 in payments from pharmaceutical and medical device companies, with $1,326 received in 2024. These payments were reported across 563 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($13,306).
As a Medicare-enrolled provider, Kaplan has provided services to 15,261 Medicare beneficiaries, totaling 38,350 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Memphis, TN
- Active Since 03/09/2006
- Last Updated 12/11/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750359543
Products in Payments
- EUCRISA (Drug) $3,761
- COSENTYX (Biological) $1,398
- EPIDUO FORTE (Drug) $1,353
- DORYX (Drug) $1,126
- VTAMA (Drug) $535.86
- TREMFYA (Drug) $512.76
- ILUMYA (Biological) $490.12
- Tremfya (Drug) $426.28
- DUPIXENT DUPILUMAB INJECTION (Biological) $382.61
- DUPIXENT (Drug) $330.10
- COSENTYX (Drug) $323.41
- SILIQ (Drug) $316.95
- DUPIXENT (Biological) $311.36
- Ilumya (Biological) $286.65
- Sotyktu (Drug) $270.49
- Humira (Biological) $265.19
- ABSORICA LD (Drug) $230.23
- Beser (Drug) $180.86
- Winlevi (Drug) $176.47
- Ameluz (Drug) $165.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Memphis
Dr. Emily Overholser, M.d, M.D
Dermatology — Payments: $253,001
Dr. Sarah Smith, M.d, M.D
Dermatology — Payments: $80,240
Dr. Alan Levy, M.d, M.D
Dermatology — Payments: $15,231
Dr. Alan Tanenbaum, M.d, M.D
Dermatology — Payments: $4,186
Dr. Alexandra Chantara, M.d, M.D
Dermatology — Payments: $4,057
Dr. Whitney Shroyer, M.d, M.D
Dermatology — Payments: $1,711